Patents by Inventor Lucille Beaudet

Lucille Beaudet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8323919
    Abstract: Methods and compositions for glycogen synthase kinase 3 assays continue to be required for detection of glycogen synthase 3 kinase, assessment of glycogen synthase 3 kinase activity and identification of modulators of glycogen synthase 3 kinase. Methods and compositions for glycogen synthase kinase 3 assays are provided herein based on the discovery of a previously unknown interaction between glycogen synthase 3 kinase and eukaryotic translation initiation factor 4E-binding protein 1 which serves as a substrate for glycogen synthase kinase 3-alpha and glycogen synthase kinase 3-beta.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: December 4, 2012
    Assignee: PerkinElmer BioSignal, Inc.
    Inventors: Roberto J. Rodriguez-Suarez, Lucille Beaudet, Mireille Caron
  • Patent number: 8242083
    Abstract: Tyrosine kinase substrates are described herein that are phosphorylated by many and diverse tyrosine kinases, and are chemically stable relative to co-polymers of poly-EY or poly-EAY having random molecular weights in the range of 20-50 kDa. Tyrosine kinase substrate peptides are provided according to embodiments described herein which include an isolated tyrosine kinase substrate peptide having molecular weight in the range of about 0.5 kD-10 kD. Tyrosine kinase substrate peptides are provided according to embodiments described herein having no more than 50 amino acids. The peptides include 2-25 phosphorylation modules and each phosphorylation module has 2-3 amino acid residues.
    Type: Grant
    Filed: June 23, 2009
    Date of Patent: August 14, 2012
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Lucille Beaudet, Philippe Roby, Julie Blouin
  • Publication number: 20110081659
    Abstract: Methods and compositions for glycogen synthase kinase 3 assays continue to be required for detection of glycogen synthase 3 kinase, assessment of glycogen synthase 3 kinase activity and identification of modulators of glycogen synthase 3 kinase. Methods and compositions for glycogen synthase kinase 3 assays are provided herein based on the discovery of a previously unknown interaction between glycogen synthase 3 kinase and eukaryotic translation initiation factor 4E-binding protein 1 which serves as a substrate for glycogen synthase kinase 3-alpha and glycogen synthase kinase 3-beta.
    Type: Application
    Filed: September 28, 2010
    Publication date: April 7, 2011
    Inventors: ROBERTO J. RODRIGUEZ-SUAREZ, LUCILLE BEAUDET, MIREILLE CARON
  • Publication number: 20100015650
    Abstract: Tyrosine kinase substrates are described herein that are phosphorylated by many and diverse tyrosine kinases, and are chemically stable relative to co-polymers of poly-EY or poly-EAY having random molecular weights in the range of 20-50 kDa. Tyrosine kinase substrate peptides are provided according to embodiments described herein which include an isolated tyrosine kinase substrate peptide having molecular weight in the range of about 0.5 kD-10 kD. Tyrosine kinase substrate peptides are provided according to embodiments described herein having no more than 50 amino acids. The peptides include 2-25 phosphorylation modules and each phosphorylation module has 2-3 amino acid residues.
    Type: Application
    Filed: June 23, 2009
    Publication date: January 21, 2010
    Applicant: PerkinElmer Health Sciences, Inc.
    Inventors: Lucille Beaudet, Philippe Roby, Julie Blouin
  • Publication number: 20070128732
    Abstract: A medium for a scintillation assay includes a fluorescent Coumarin dye, typically having a Stokes shift of at least 50 nm and a fluorescence in the range of 460-500 nm. The composition may further include secondary scintillator materials which as PPO, DPA, bis-MSB, BiBuQ, and the like. The scintillator medium may be a liquid medium or a solid medium. Also disclosed is an assay utilizing the material of the present invention, as well as a specifically solid-state scintillator medium incorporating Coumarin 153 and BiBuQ.
    Type: Application
    Filed: July 2, 2004
    Publication date: June 7, 2007
    Inventors: Lucille Beaudet, Martin Boissonneault, Philippe Roby